Zogenix Inc. (NASDAQ:ZGNX) was down 4.2% during trading on Thursday . The company traded as low as $8.55 and last traded at $8.61, with a volume of 87,016 shares trading hands. The stock had previously closed at $8.99.

A number of equities research analysts have commented on ZGNX shares. Brean Capital reiterated a “buy” rating and issued a $28.00 price target on shares of Zogenix in a research note on Wednesday, May 11th. Zacks Investment Research cut Zogenix from a “hold” rating to a “sell” rating in a research note on Wednesday. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $22.75.

The stock has a market cap of $214.27 million and a price-to-earnings ratio of 5.12. The firm’s 50-day moving average price is $8.90 and its 200 day moving average price is $9.89.

Zogenix (NASDAQ:ZGNX) last issued its quarterly earnings data on Tuesday, May 10th. The company reported ($0.42) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.62) by $0.20. During the same period in the previous year, the firm posted ($1.19) earnings per share. The firm earned $9.20 million during the quarter, compared to analyst estimates of $4.90 million. The company’s quarterly revenue was up 100.0% compared to the same quarter last year. On average, equities research analysts anticipate that Zogenix Inc. will post ($3.13) EPS for the current fiscal year.

Several large investors have recently modified their holdings of the stock. Pyrrho Capital Management LP boosted its stake in shares of Zogenix by 13.7% in the fourth quarter. Pyrrho Capital Management LP now owns 148,260 shares of the company’s stock worth $2,185,000 after buying an additional 17,860 shares during the last quarter. J. Goldman & Co LP boosted its position in Zogenix by 72.1% in the fourth quarter. J. Goldman & Co LP now owns 149,500 shares of the company’s stock valued at $2,204,000 after buying an additional 62,615 shares during the last quarter. Finally, Cornerstone Capital Management Holdings LLC. boosted its position in Zogenix by 400.1% in the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 78,456 shares of the company’s stock valued at $1,156,000 after buying an additional 62,769 shares during the last quarter.

Zogenix, Inc is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with orphan and other CNS disorders in requirement of treatment alternatives. The Company’s areas of focus are epilepsy and schizophrenia.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.